RUNX3 and neoplasm: Also, it remains an open question whether cytoplasmic RUNX3 holds some oncogenic effects, since to date no publication refers to the possible pro‐tumour role of cytoplasmic RUNX3, independent of the loss of its tumour‐suppressor effects due to nuclear dislocation.